Medicine & Life Sciences
Fecal Incontinence
100%
dextranomer
93%
Safety
63%
Electric Stimulation
49%
Conservative Treatment
48%
Injections
47%
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
44%
Clinical Trials Data Monitoring Committees
41%
Sensory Thresholds
39%
Therapeutics
35%
Quality of Life
35%
Organized Financing
32%
Manuals
31%
Anal Canal
30%
Diaries
29%
Research Ethics Committees
28%
Data Accuracy
28%
Clinical Protocols
27%
Practice Guidelines
25%
Industry
25%
Compliance
24%
Health Care Costs
24%
Cost-Benefit Analysis
23%
Colon
21%
Randomized Controlled Trials
18%
Pressure
17%
Costs and Cost Analysis
16%
Equipment and Supplies
16%